carbostyril has been researched along with Lymph Node Metastasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Day, AG; Elliott, BE; Ghaffari, A; Greer, PA; Hoskin, V; Kiefer, F; Madarnas, Y; Mewburn, J; Mullins, G; SenGupta, S; Turashvili, G; Varma, S | 1 |
| Ahn, JS; Ahn, MJ; Ahn, S; Cho, BC; Choi, YL; Kim, HR; Kim, JH; Lee, JY; Lee, SH; Lim, SH; Park, K; Sun, JM | 1 |
1 trial(s) available for carbostyril and Lymph Node Metastasis
| Article | Year |
|---|---|
Efficacy and safety of dovitinib in pretreated patients with advanced squamous non-small cell lung cancer with FGFR1 amplification: A single-arm, phase 2 study.
Topics: Aged; Aged, 80 and over; Benzimidazoles; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Gene Amplification; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prognosis; Quinolones; Receptor, Fibroblast Growth Factor, Type 1; Survival Rate | 2016 |
1 other study(ies) available for carbostyril and Lymph Node Metastasis
| Article | Year |
|---|---|
Intravital imaging reveals systemic ezrin inhibition impedes cancer cell migration and lymph node metastasis in breast cancer.
Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Breast; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cohort Studies; Cytoskeletal Proteins; Disease Models, Animal; Female; Genes, Reporter; Humans; Intravital Microscopy; Lung; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mice; Mice, Inbred C57BL; Mice, Transgenic; Middle Aged; Neoplasm Recurrence, Local; Phenols; Quinolones; Tissue Array Analysis | 2019 |